![](/img/cover-not-exists.png)
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis
Hughes, Bruce, Cascione, Mark, Freedman, Mark S., Agius, Mark, Kantor, Daniel, Gudesblatt, Mark, Goldstick, Lawrence P., Agashivala, Neetu, Schofield, Lesley, McCague, Kevin, Hashmonay, Ron, Barbato,Volume:
3
Language:
english
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2014.06.006
Date:
September, 2014
File:
PDF, 528 KB
english, 2014